On December 1, 2022 Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later
On September 16, 2022 Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3M-052 liposomes): In vitro characterization
On September 7, 2022 Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection
On June 19, 2020 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates